Literature DB >> 16872778

Role of astrocytes in estrogen-mediated neuroprotection.

Krishnan M Dhandapani1, Darrell W Brann.   

Abstract

Recent work has suggested that the ovarian steroid hormone, 17beta-estradiol (E2), at physiological concentrations, may exert protective effects in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and acute ischemic stroke. While physiological concentrations of E2 have consistently been shown to be protective in vivo, direct protection of neurons remains controversial, suggesting that while direct protection of neurons may occur in some instances, an alternative or parallel pathway for protection may exist which could involve another cell type in the brain. In the present review, we summarize the data in support of a possible role for astrocytes in the mediation of neuroprotection by E2. We also summarize the data suggesting a non-classical estrogen receptor may underlie some of the protective effects of E2 by activating cellular signaling pathways, such as extracellular-regulated kinase (ERK) and phosphatidylinositol 3-kinase/Akt. A possible indirect pathway involving astrocytes may act in concert with the proposed direct pathway to achieve a widespread, global protection of both ER positive and negative neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872778     DOI: 10.1016/j.exger.2006.06.032

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  41 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  GnRH analogue attenuated apoptosis of rat hippocampal neuron after ischemia-reperfusion injury.

Authors:  Chenyu Chu; Bainan Xu; Weiquan Huang
Journal:  J Mol Histol       Date:  2010-10-15       Impact factor: 2.611

3.  Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain.

Authors:  Ana Navarro; Eva Del Valle; Cristina Ordóñez; Eva Martínez; Cristina Pérez; Ana Alonso; Celestino González; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2012-05-10

4.  Estrogen actions on neuroendocrine glia.

Authors:  Paul Micevych; Galyna Bondar; John Kuo
Journal:  Neuroendocrinology       Date:  2010-03-24       Impact factor: 4.914

5.  Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice.

Authors:  James Johnson; Edward Alain B Pajarillo; Equar Taka; Romonia Reams; Deok-Soo Son; Michael Aschner; Eunsook Lee
Journal:  Neurotoxicology       Date:  2017-06-10       Impact factor: 4.294

6.  Norepinephrine regulation of ventromedial hypothalamic nucleus metabolic transmitter biomarker and astrocyte enzyme and receptor expression: Impact of 5' AMP-activated protein kinase.

Authors:  Mostafa M H Ibrahim; Hussain N Alhamami; Karen P Briski
Journal:  Brain Res       Date:  2019-01-07       Impact factor: 3.252

Review 7.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 8.  The cerebellum as a target for estrogen action.

Authors:  Valerie L Hedges; Timothy J Ebner; Robert L Meisel; Paul G Mermelstein
Journal:  Front Neuroendocrinol       Date:  2012-09-05       Impact factor: 8.606

9.  Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol.

Authors:  Joachim G Elzer; Sajjad Muhammad; Tim M Wintermantel; Anne Regnier-Vigouroux; Jochen Ludwig; Günther Schütz; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

10.  Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.

Authors:  Li-cai Yang; Quan-Guang Zhang; Cai-feng Zhou; Fang Yang; Yi-dong Zhang; Rui-min Wang; Darrell W Brann
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.